Immunogenicity and protective effects of inactivated Singapore grouper iridovirus (SGIV) vaccines in orange-spotted grouper, Epinephelus coioides

Developmental and Comparative Immunology

Volumn 38, Issue 2, 2012, Pages 254-261

  Ou yang, Zhengliang ^a   Wang, Peiran ^b   Huang, Xiaohong ^a   Cai, Jia ^a   Huang, Youhua ^a   Wei, Shina ^a   Ji, Huasong ^c   Wei, Jingguang ^a   Zhou, Yongcan ^c   Qin, Qiwei ^a  

^a SOUTH CHINA SEA INSTITUTE OF OCEANOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HAINAN UNIVERSITY   (China)

Author keywords

ELISA; Formalin; Immune related genes; Inactivated vaccine; Singapore grouper iridovirus (SGIV); propiolactone

Indexed keywords

CYTOKINE; FORMALDEHYDE; INACTIVATED VACCINE; INTERFERON; PROPIOLACTONE; SINGAPORE GROUPER IRIDOVIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EPINEPHELUS COIOIDES; FISH; GENE; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNOGENICITY; INNATE IMMUNITY; ISG15 GENE; MHC CLASS I GENE; MX GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SURVIVAL RATE; UPREGULATION; VIRUS INACTIVATION; VIRUS INFECTION;

EPINEPHELINAE; EPINEPHELUS COIOIDES; SINGAPORE GROUPER IRIDOVIRUS;

EID: 84866144765     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2012.07.004     Document Type: Article

References (57)

1. Amend D.F. Potency testing of fish vaccines. International symposium on fish. Biologics: serodiagnostics and vaccines. Dev. Biol. Stand. 1981, 49:447-454.
2. Bachmann M.F., Bast C., Hengartner H., Zinkernagel R.M. Immunogenicity of a viral model vaccine after different inactivation procedures. Med. Microbiol. Immunol. 1994, 183:95-104.
3. Biering E., Villoing S., Sommerset I., Christie K.E. Update on viral vaccines for fish. Dev. Biol. (Basel) 2005, 121:97-113.
4. Biron C.A. Interferons alpha and beta as immune regulators - A new look. Immunity 2001, 14:661-664.
5. Burstyn D., Hageman T. Strategies for viral removal and inactivation. Dev. Biol. Stand. 1996, 88:73.
6. Burton D.R. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2002, 2:706-713.
7. Caipang C.M.A., Hirono I., Aoki T. Immunogenicity, retention and protective effects of the protein derivatives of formalin-inactivated red seabream iridovirus (RSIV) vaccine in red seabream, Pagrus major. Fish Shellfish Immunol. 2006, 20:597-609.
8. Castilow E.M., Olson M.R., Varga S.M. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. Immunol. Res. 2007, 39:225-239.
9. Cheng C.A., John J.A., Wu M.S., Lee C.Y., Lin C.H., Chang C.Y. Characterization of serum immunoglobulin M of grouper and cDNA cloning of its heavy chain. Vet. Immunol. Immunopathol. 2006, 109:255-265.
10. Chinchar V., Essbauer S., He J., Hyatt A., Miyazaki T., Seligy V., Williams T. Iridoviridae. Virus taxonomy: 8th Report of the International Committee on the Taxonomy of Viruses 2005, Elsevier 1259, London, 163-175.
11. Cresswell P. Assembly, transport, and function of MHC class II molecules. Ann. Rev. Immunol. 1994, 12:259-293.
12. Dixon P.F., Hill B.J. Inactivation of infectious pancreatic necrosis virus for vaccine use. J. Fish Dis. 1983, 6:399-409.
13. Evensen O., Haugland O., Torgersen J., Syed M. Expression profiles of inflammatory and immune-related genes in Atlantic salmon (Salmo salar L.) at early time post vaccination. Vaccine 2005, 23:5488-5499.
14. Furesz J. Developments in the production and quality control of poliovirus vaccines - Historical perspectives. Biologicals 2006, 34:87-90.
15. Gard S. Theoretical considerations in the inactivation of viruses by chemical means. Ann. N. Y. Acad. Sci. 1960, 83:638-648.
16. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Ann. Rev. Immunol. 2001, 19:65-91.
17. Hansen J.D., Zapata A.G. Lymphocyte development in fish and amphibians. Immunol. Rev. 1998, 166:199-220.
18. Hansen J.D., La Patra S. Induction of the rainbow trout MHC class I pathway during acute IHNV infection. Immunogenetics 2002, 54:654-661.
19. Horowitz B., Ben-Hur E. Strategies for viral inactivation. Curr. Opin. Hematol. 1995, 2:484.
20. Huang C., Zhang X., Gin K.Y., Qin Q.W. In situ hybridization of a marine fish virus, Singapore grouper iridovirus with a nucleic acid probe of major capsid protein. J. Virol. Methods 2004, 117:123-128.
21. Huang X.H., Huang Y.H., Gong J., Yan Y., Qin Q.W. Identification and characterization of a putative lipopolysaccharide-induced TNF-alpha factor (LITAF) homolog from Singapore grouper iridovirus. Biochem. Biophys. Res. Commun. 2008, 373:140-145.
22. Huang X.H., Huang Y.H., Sun J.J., Han X., Qin Q. Characterization of two grouper Epinephelus akaara cell lines: application to studies of Singapore grouper iridovirus (SGIV) propagation and virus-host interaction. Aquaculture 2009, 292:172-179.
23. Jiang B.M., Wang Y.H., Saluzzo J.F., Bargeron K., Frachette M.J., Glass R.I. Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum. Vaccines 2008, 4:143-147.
24. Jung T.S., Jang H.B., Kim Y.R., Cha I.S., Noh S.W., Park S.B., Ohtani M., Hikima J., Aoki T. Detection of antigenic proteins expressed by lymphocystis virus as vaccine candidates in olive flounder, Paratichthys olivaceus (Temminck and Schlegel). J. Fish Dis. 2011, 34:555-562.
25. Kümmerer K. Effects of antibiotics and virustatics in the environment. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks 2008, 223-244. Springer, Berlin Heidelberg, New York. K. Kümmerer (Ed.).
26. Lawrence S. Beta-propiolactone and aziridine: their applications in organic synthesis and viral inactivation. Chim. Oggi 1999, 17:51-54.
27. Lawrence S.A. Beta-propiolactone: viral inactivation in vaccines and plasma products. PDA J. Pharm. Sci. Technol. 2000, 54:209-217.
28. Leong J.A.C., Kim C.H., Johnson M.C., Drennan J.D., Simon B.E., Thomann E. DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish. J. Virol. 2000, 74:7048-7054.
29. Lorenzen N., Lorenzen E., Einer-Jensen K., LaPatra S.E. DNA vaccines as a tool for analysing the protective immune response against rhabdoviruses in rainbow trout. Fish Shellfish Immunol. 2002, 12:439-453.
30. Maniero G.D., Morales H., Gantress J., Robert J. Generation of a long-lasting, protective, and neutralizing antibody response to the ranavirus FV3 by the frog Xenopus. Dev. Comp. Immunol. 2006, 30:649-657.
31. Martin J., Crossland G., Wood D.J., Minor P.D. Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains. J. Gen. Virol. 2003, 84:1781-1788.
32. Nakajima K., Maeno Y., Kurita J., Inui Y. Vaccination against red sea bream iridoviral disease in red sea bream. Fish Pathol. 1997, 32:205-209.
33. Nakajima K., Maeno Y., Yokoyama K., Kaji C., Manabe S. Antigen analysis of red sea bream iridovirus and comparison with other fish iridoviruses. Fish Pathol. 1998, 33:73-78.
34. Nakajima K., Maeno Y., Honda A., Yokoyama K., Tooriyama T., Manabe S. Effectiveness of a vaccine against red sea bream iridoviral disease in a field trial test. Dis. Aquat. Organ. 1999, 36:73-75.
35. Nakanishi T., Toda H., Shibasaki Y., Somamoto T. Cytotoxic T cells in teleost fish. Dev. Comp. Immunol. 2011, 35(12):1317-1323.
36. Oh Y.K., Harding C.V., Swanson J.A. The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation. Vaccine 1997, 15:511-518.
37. Ou-yang Z.L., Huang X.H., Huang E.Y., Huang Y.H., Gong J., Sun J.J., Qin Q.W. Establishment and characterization of a new marine fish cell line derived from red-spotted grouper Epinephelus akaara. J. Fish Biol. 2010, 77:1083-1095.
38. Ou-yang Z.L., Wang P.R., Huang Y.H., Huang X.H., Wan Q.J., Zhou S., Wei J.G., Zhou Y.C., Qin Q.W. Selection and identification of Singapore grouper iridovirus vaccine candidate antigens using bioinformatics and DNA vaccination. Vet. Immunol. Immunopathol. 2012, http://dx.doi.org/10.1016/j.vetimm.2012.
39. Pakingking R., Seron R., dela Pena L., Mori K., Yamashita H., Nakai T. Immune responses of Asian sea bass, Lates calcarifer bloch, against an inactivated betanodavirus vaccine. J. Fish Dis. 2009, 32:457-463.
40. Qin Q.W., Shi C.Y., Gin K.Y.H., Lam T.J. Antigenic characterization of a marine fish iridovirus from grouper Epinephelus spp. J. Virol. Methods 2002, 106:89-96.
41. Qin Q.W., Chang S.F., Ngoh-Lim G.H., Gibson-Kueh S., Shi C., Lam T.J. Characterization of a novel ranavirus isolated from grouper Epinephelus tauvina. Dis. Aquat. Organ. 2003, 53:1-9.
42. Qin Q.W., Lam T.J., Sin Y.M., Shen H., Chang S.F., Ngoh G.H., Chen C.L. Electron microscopic observations of a marine fish iridovirus isolated from brown-spotted grouper Epinephelus tauvina. J. Virol. Methods 2001, 98:17-24.
43. Raida M.K., Buchmann K. Temperature-dependent expression of immune-relevant genes in rainbow trout following Yersinia ruckeri vaccination. Dis. Aquat. Organ. 2007, 77:41-52.
44. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
45. Robertsen B. Expression of interferon and interferon-induced genes in salmonids in response to virus infection, interferon-inducing compounds and vaccination. Fish Shellfish Immunol. 2008, 25:351-357.
46. Ruggeri F.M., Monini M. Antigenic peptides of the epizootic hematopoietic necrosis virus. Virology 2002, 297:8-18.
47. Siwicki A.K., Lepa A., Terech-Majewska E. Application of DNA vaccines in fish. Pol. J. Vet. Sci. 2010, 13:213-215.
48. Somamoto T., Nakanishi T., Okamoto N. Specific cell-mediated cytotoxicity against a virus-infected syngeneic cell line in isogeneic ginbuna crucian carp. Dev. Comp. Immunol. 2000, 24:633-640.
49. Somamoto T., Nakanishi T., Okamoto N. Role of specific cell-mediated cytotoxicity in protecting fish from viral infections. Virology 2002, 297:120-127.
50. Sommerset I., Krossoy B., Biering E., Frost P. Vaccines for fish in aquaculture. Expert Rev. Vaccines 2005, 4:89-101.
51. Srikram A., Wongratanacheewin S., Puapairoj A., Wuthiekanun V., Sermswan R.W. Analyses of vaccination protocols for Leptospira interrogans serovar autumnalis in hamsters. Am. J. Trop. Med. Hyg. 2008, 79:779-786.
52. Stein C., Caccamo M., Laird G., Leptin M. Conservation and divergence of gene families encoding components of innate immune response systems in zebrafish. Genome Biol. 2007, 8(11):R251.
53. Tiwari M., Parida M., Santhosh S.R., Khan M., Dash P.K., Rao P.V.L. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Vaccine 2009, 27:2513-2522.
54. Tough D.F., Le Bon A. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 2002, 14:432-436.
55. Yamashita H., Fujita Y., Kawakami H., Nakai T. The efficacy of inactivated virus vaccine against viral nervous necrosis (VNN). Fish Pathol. 2005, 40:15-21.
56. Yoshimizu M., Iwamoto R. The development of protective vaccine against Japanese flounder lymphocystis disease using an inactivated virus 2001, Fish Disease Center News, Annual Reports of Fish Disease Control FIDIC, 1-14.
57. Zwollo P., Cole S., Bromage E., Kaattari S. B cell heterogeneity in the teleost kidney: evidence for a maturation gradient from anterior to posterior kidney. J. Immunol. 2005, 174:6608-6616.